PharmiWeb1d
POP Biotechnologies Announces Phase 3 Trial Interim Results Published for COVID-19 Vaccine Based on POP BIO SNAP(TM)
BUFFALO, NY / ACCESSWIRE / September 27, 2024 / POP Biotechnologies (POP BIO), a Buffalo, NY-based biopharmaceutical company, ...
PharmiWeb1d
POP Biotechnologies Announces Phase 3 Trial Interim Results Published for COVID-19 Vaccine Based on POP BIO SNAP™
EuCorVac-19 EuCorVac-19, a COVID-19 vaccine candidate developed by EuBiologics and POP Biotechnologies BUFFALO, N.Y., ...
PharmiWeb2d
MasterWord and UNESCO Join Forces to Preserve and Digitize Mayan Languages for Future Generations
HOUSTON, TX / ACCESSWIRE / September 27, 2024 / MasterWord is honored to announce its partnership with UNESCO, within its ...
PharmiWeb2d
CF AMR Syndicate Announces First Awardees of £3m Collaborative Drug Discovery Programme
Syndicate has today announced the first cohort of awardees of its Collaborative Discovery Programme (CDP) funding.The £3 ...
PharmiWeb2d
Global AMR Challenge Receives a £5m Boost to Drive Diagnostics Innovation
PACE (Pathways to Antimicrobial Clinical Efficacy) has today launched its second funding round with up to £5 million ...
PharmiWeb2d
Diabetic Gastroparesis Treatment Market: Rising Demand Sparks Innovation and Research
The global diabetic gastroparesis treatment market is poised for significant growth, driven by the increasing prevalence of ...
PharmiWeb2d
SmartHMS Revolutionizes Healthcare Management with Its Advanced SMARTHMIS Software
SmartHMS, a leading healthcare management solutions provider based in India, is proud to announce the ongoing success and ...
PharmiWeb2d
Humaneva Group Secures Major US Private Equity Investment to Accelerate Global Clinical Research Market Expansion
Humaneva CEO - Tomasz D?browski WARSAW, Poland, September 27, 2024 (Newswire.com) - Humaneva Inc. has entered into a ...
PharmiWeb3d
Los Angeles Medical Waste Disposal Company Responds to Rise in Needlestick Injuries With In-Depth Guide
The CDC reports that healthcare workers in the U.S. face an estimated 385,000 needlestick and sharps-related injuries every ...
PharmiWeb2d
Baxter Launches Next Generation of THE VEST for Airway Clearance
Baxter International Inc. (NYSE:BAX), a leading global medtech company, today unveiled its next generation airway clearance ...
PharmiWeb4d
GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis
ANKARA, TURKEY / ACCESSWIRE / September 25, 2024 / GEN Pharmaceuticals (GENIL.IS), a leading Turkish pharmaceutical company, ...
PharmiWeb2d
Dupixent approved in the US as the first-ever biologic medicine for patients with COPD
Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotypeFollowing recent approvals in the EU and China, the US approval is ...